BioWorld

Dec. 2, 2010

View Archived Issues

NewCo News: Acylin Pharma Explores 'Blooming' Acetylation Field

Read More

Germany's SuppreMol Raises $20.3M, Secures Path to 2013

Read More

Clinic Roundup

Read More

Stock Movers

Read More

Other News To Note

Read More

Axcan Agrees to Acquire Eurand in $583M Deal

Axcan Holdings Inc. will acquire Eurand NV for $12 per share in cash, a $583 million transaction that the companies expect to close in the second quarter of 2011. (BioWorld Today) Read More

Bayh-Dole Brought Shelved Inventions to Marketplace

Read More